United States · FDA National Drug Code directory
DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85722-0002_9cb5da4e-9175-4339-83da-fc22448b2e80
- Product NDC
- 85722-0002
- Form
- SYRUP
- Composition / generic term
- DEXTROMETHORPHAN HYDROBROMIDE and GUAIFENESIN
- Labeler
- KJD Pharma Private Limited
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20210201
- Source listing expiry
- 20261231
Source-listed ingredients
- DEXTROMETHORPHAN HYDROBROMIDE — 20 mg/5mL
- GUAIFENESIN — 300 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 118 mL in 1 BOTTLE (85722-0002-4) · 85722-0002-4
- 473 mL in 1 BOTTLE (85722-0002-6) · 85722-0002-6
- 236 mL in 1 BOTTLE (85722-0002-8) · 85722-0002-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →